Stock Scorecard
Stock Summary for BlackRock Health Sciences Term Trust (BMEZ) - $14.69 as of 4/24/2024 7:38:26 PM EST
Total Score
14 out of 29
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for BMEZ
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BMEZ
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BMEZ
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for BMEZ
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for BMEZ
Financial Details for BMEZ
Company Overview |
|
|---|---|
| Ticker | BMEZ |
| Company Name | BlackRock Health Sciences Term Trust |
| Country | USA |
| Description | N/A |
| Sector Name | TECHNOLOGY |
| Industry Name | GENERAL |
| Most Recent Quarter | 12/31/2020 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 14.69 |
| Last Day Price Updated | 4/24/2024 7:38:26 PM EST |
| Last Day Volume | 296,069 |
| Average Daily Volume | 258,928 |
| 52-Week High | 16.40 |
| 52-Week Low | 12.47 |
| Last Price to 52 Week Low | 17.80% |
Valuation Measures |
|
| Trailing PE | 27.35 |
| Industry PE | 23.66 |
| Sector PE | 74.96 |
| 5-Year Average PE | -2.76 |
| Free Cash Flow Ratio | 0.00 |
| Industry Free Cash Flow Ratio | 40.35 |
| Sector Free Cash Flow Ratio | 28.93 |
| Current Ratio Most Recent Quarter | 0.00 |
| Total Cash Per Share | 0.00 |
| Book Value Per Share Most Recent Quarter | 29.78 |
| Price to Book Ratio | 0.84 |
| Industry Price to Book Ratio | 31.21 |
| Sector Price to Book Ratio | 14.93 |
| Price to Sales Ratio Twelve Trailing Months | 22.48 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.64 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.67 |
Share Statistics |
|
| Total Shares Outstanding | 106,514,000 |
| Market Capitalization | 1,564,690,660 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 4/12/2024 |
| Last Dividend Amount | 0.09 |
| Current Dividend Amount | 0.09 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 1.36 |
| Trailing Annual Dividend Yield | 9.29% |
| Forward Annual Dividend Rate | 1.35 |
| Forward Annual Dividend Yield | 9.20% |
| 5-Year Dividend Payments Count | 40 |
| 3-Year Average Dividend Yield | 9.48% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | -9.05% |
| 3-Year Dividend Growth Rate Percentage | -0.92% |
| 5-Year Dividend Growth Rate Percentage | -0.92% |
| All-Time Dividend Growth Rate Percentage | -0.92% |
| Dividend Payout Ratio | 252.59% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 1,211.50% |
| Reported EPS 12 Trailing Months | 0.54 |
| Reported EPS Past Year | -6.07 |
| Reported EPS Prior Year | -2.56 |
| Net Income Twelve Trailing Months | 0 |
| Net Income Past Year | 1,485,000,026 |
| Net Income Prior Year | 113,229,299 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | 1,207.49% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 0 |
| Total Cash Past Year | 33,690 |
| Total Cash Prior Year | 33,690 |
| Net Cash Position Most Recent Quarter | 0 |
| Net Cash Position Past Year | 33,690 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 3,023,744,008 |
| Total Stockholder Equity Prior Year | 3,023,744,008 |
| Total Stockholder Equity Most Recent Quarter | 3,355,652,954 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.36 |
| MACD Signal | -0.28 |
| 20-Day Bollinger Lower Band | 13.79 |
| 20-Day Bollinger Middle Band | 15.29 |
| 20-Day Bollinger Upper Band | 16.79 |
| Beta | 0.00 |
| RSI | 33.28 |
| 50-Day SMA | 14.71 |
| 200-Day SMA | 16.93 |
System |
|
| Modified | 4/24/2024 7:38:29 PM EST |